AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

ADIL · NASDAQ · Biotechnology

Adial Pharmaceuticals (ADIL)

Develops precision-oriented therapies for ulcerative colitis and genetically selected alcohol use disorder patients.

$6.17

Pre-market−0.23 (−3.59%)

At close$6.40(+7.56%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions15 holders · as of Mar 31, 2026	1.36%	35.6K shares
Insiders6 holders · as of Jun 16, 2026	15.37%	403.6K shares
Strategic holders1 holder · as of Jul 16, 2026	14.79%	388.3K shares
Otherremainder	68.48%	1.80M shares

2.63M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (2.63M in the company's Sep 3, 2026 report, 959.6K elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Coastlands Capital LPStrategic10 percent owner	14.79%	388,308	Form 4filed Jul 16, 2026 ↗
Matt DavidsonInsiderdirector, officer: Chief Development Officer	11.46%	300,918	Form 4filed Jun 16, 2026 ↗
Cary J. ClaiborneInsiderdirector, officer: Chief Executive Officer	1.54%	40,417	Form 4filed Apr 9, 2026 ↗
Tony GoodmanInsiderdirector, officer: Chief Operating Officer	1.01%	26,523	Form 4filed Apr 9, 2026 ↗
Geode Capital Management, LLCInstitution	0.92%	24,249	13Fas of Mar 31, 2026
Vinay ShahInsiderofficer: Chief Financial Officer	0.66%	17,325	Form 4filed Apr 9, 2026 ↗
Kevin SchuylerInsiderdirector	0.35%	9,213	Form 4filed Apr 9, 2026 ↗
Robertson H. GillilandInsiderdirector	0.35%	9,185	Form 4filed Apr 9, 2026 ↗
Vanguard Fiduciary Trust CoInstitution	0.22%	5,879	13Fas of Mar 31, 2026
Manchester Capital Management LLCInstitution	0.07%	1,923	13Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution	0.05%	1,356	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	0.04%	1,110	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.02%	542	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	0.01%	361	13Fas of Mar 31, 2026
Raffa Wealth Management, LLCInstitution	0.00%	83	13Fas of Mar 31, 2026
Morgan StanleyInstitution	0.00%	50	13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution	0.00%	47	13Fas of Mar 31, 2026
Caitong International Asset Management Co., LtdInstitution	0.00%	15	13Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution	0.00%	6	13Fas of Mar 31, 2026
Northwestern Mutual Wealth Management CoInstitution	0.00%	4	13Fas of Mar 31, 2026
Harbour Investments, Inc.Institution	0.00%	3	13Fas of Mar 31, 2026
Abound Wealth ManagementInstitution	0.00%	1	13Fas of Mar 31, 2026
Armistice Capital, LLCStrategic	—9.99% of class, as filed	—	13Gfiled Feb 18, 2026 ↗
Empery Asset Management, LPInstitution	—4.99% of class, as filed	—	13G/Afiled Jan 21, 2020 ↗
Howard PeikinInsider	—4.40% of class, as filed	—	13G/Afiled Feb 14, 2022 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

15 holders · 35.6K shares

Holder	Shares	% outstanding	Filed
Geode Capital Management, LLC	24.2K	0.92%	May 15, 2026
Vanguard Fiduciary Trust Co	5.9K	0.22%	May 8, 2026
Manchester Capital Management LLC	1.9K	0.07%	May 11, 2026
Tower Research Capital LLC (TRC)	1.4K	0.05%	May 15, 2026
BlackRock, Inc.	1.1K	0.04%	May 13, 2026
UBS Group AG	542	0.02%	May 5, 2026
Vanguard Capital Management LLC	361	0.01%	May 15, 2026
Raffa Wealth Management, LLC	83	0.00%	Jul 27, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Coastlands Capital LP	14.22%	373.3K	13G	Jul 1, 2026 ↗
Armistice Capital, LLC	9.99%		13G	Feb 18, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jul 14, 2026	Coastlands Capital LP10 percent owner	Purchase	2,000	$2.65	387,075
Jul 16, 2026	Coastlands Capital LP10 percent owner	Purchase	1,233	$2.75	388,308
Jul 9, 2026	Coastlands Capital LP10 percent owner	Purchase	10,053	$2.79	383,375
Jul 10, 2026	Coastlands Capital LP10 percent owner	Purchase	1,700	$2.70	385,075
Jun 29, 2026	Coastlands Capital LP10 percent owner	Purchase	25,000	$2.60	373,322
Jun 12, 2026	Wendy B. Youngdirector	Purchase	36,378	$0.0010	36,378

CongressHouse and Senate disclosures

Not reported.